apoptosis (programmed cell death)
DESCRIPTION
Apoptosis (Programmed Cell Death). Apoptosis vs Necrosis. Level of stress, change in environment. stress. apoptosis. necrosis. A pathological response to injury Chromatin clumping Mitochondria swelling and rupture Plasma membrane lyses Cell contents spill out. - PowerPoint PPT PresentationTRANSCRIPT
ApoptosisApoptosis(Programmed Cell Death)(Programmed Cell Death)
Apoptosis vs Necrosis
• Level of stress, change in environment
stress
apoptosis necrosis
Modes of Cell Death
• A pathological response to injury
• Chromatin clumping• Mitochondria swelling and
rupture• Plasma membrane lyses• Cell contents spill out
• A normal physiological response to specific suicide signals
• Chromatin condenses• Internucleosomal
cleavage leads to laddering of DNA
• Cytoplasma shrinks without membrane rupture
• Blebbing of plasma and nuclear membranes
• No spillage
Necrosis Apoptosis
Tumor Suppressor Genes
• Tumor-suppressor genes, function like brakes, keep cell numbers down, either by:
1. Inhibiting progress through the cell cycle and thereby preventing cell birth, or
2. Promoting apoptosis
• When cellular tumor suppressor genes are rendered non-functional through mutation, the cell becomes malignant. Example: pRb, p53, and p16INK4a.
Oncogenes
• Oncogenes stimulate cells to grow (or refuse to die).
• Mutated oncogenes can stimulate cells even when they are not receiving growth signals. Example: Ras, Akt, Survivin.
• Amplification of oncogenes is also found in cancer. Example: MDM2.
Apoptosis Signaling Pathway
Cell, 2002;108:153-64
Tumor-derived mutations affecting apoptosis
Protein Role in apoptosisReferences
p53 Mutated or altered expression in many cancers. Initiates the intrinsic apoptotic pathway.
Vogelstein et al., 2000
p19ARF Mutated or altered expression in many cancers. Blocks MDM2 inhibition of p53. Enhances drug-induced apoptosis by p53.
Sherr and Weber, 2000
pRb Mutated in some cancers, and functionally disrupted in many cancers. Inhibits E2F-mediated transcription.
Harbour and Dean, 2000
FLIP Overexpressed in some cancers. Prevents activation of caspase-8 and apoptosis induced by some chemotherapeutic drugs.
Tepper and Seldin, 1999
Tumor-derived mutations affecting apoptosis
Protein Role in apoptosisReferences
Apaf-1 Mutated and transcriptionally silenced in melanoma and leukemia cell lines. Necessary for activation of caspase-9 following cytochrome c release. Apaf-1-/- cells are chemoresistant.
Soengas et al., 2001
CD-95/Fas
Mutated and down-regulated in lymphoid and solid tumors. Initiates the extrinsic apoptotic pathway. Loss of function is associated with resistance to drug-induced cell death.
Muschen et al., 2000
TRAIL Mutated in metastatic breast cancers. Initiate the extrinsic apoptotic pathway. Mutations lead to suppression of death receptor-mediated apoptosis.
Shin et al., 2001
Caspase-8
Gene silenced in neuroblastomas. Activates both extrinsic and intrinsic apoptotic pathways. Silencing results in resistance to drug-induced apoptosis.
Teitz et al., 2000
Tumor-derived mutations affecting apoptosis
Protein Role in apoptosis References
Bcl2 Frequently overexpressed in many tumors. Antagonises Bax and/or Bak and inhibits mitochondrial membrane disruption. Inhibits drug-induced apoptosis.
Reed, 1999
MDM2 Overexpressed in some tumors. Negative regulator of p53. Inhibits drug-induced p53 activation.
Sherr and Weber, 2000
IAPs Frequently overexpressed in cancer. Down regulation of XIAP induces apoptosis in chemoresistant tumors.
Deveraux and Reed, 1999
NFB Transcriptionally activates expression of anti-apoptotic members of the Bcl-2 and IAP families. Can inhibit both the extrinsic and intrinsic death pathways and induce drug-resistance.
Baldwin, 2001
Tumor-derived mutations affecting apoptosis
Protein Role in apoptosis Ref
Myc Induces proliferation in the presence of survival factors, such as Bcl-2, and apoptosis in the absence of survival factors.
Evan and Vousden, 2001
Akt Frequently amplified in cancers. Phosphorylates Bad. Hyperactivation induces resistance to a range of apoptotic stimuli including drugs.
Datta et al., 1999
PI3K Overexpressed in some cancers. Responsible for activation of Akt and downstream phosphorylation of Bad. Inhibition of PI3K enhances chemotherapeutic drug-induced apoptosis.
Roymans and Slegers, 2001
Ras Mutated or deregulated in many cancers. Activates PI3K and downstream pathways. Induces proliferation and inhibits c-myc and drug-induced apoptosis.
el-Deiry, 1997
Tumor-derived mutations affecting apoptosis
Protein Role in apoptosisReferences
Bax Mutated or decreased expression in some tumors. Mediates mitochondrial membrane damage. Sufficient but not necessary for drug-induced apoptosis.
Rampino et al., 1997
Bak Mutated or decreased expression in some tumors. Mediates mitochondrial membrane damage. Sufficient but not necessary for drug-induced apoptosis.
Kondo et al., 2000
PTEN Mutated or altered expression in cancers. Regulates Akt activation and subsequent phosphorylation of Bad. Loss of PTEN results in resistance to many apoptotic stimuli.
Di Cristofano and Pandolfi, 2000
Role of p53 in Apoptosis
1. p53 induces apoptosis through transcriptional activation of proapoptotic genes, such as Puma, Noxa, p53AIP, Bax, Apaf-1, etc.
2. It can also directly induce apoptosis by localizing to mitochondria via interaction with Bcl-2 family protein.
Nat Rev Cancer, 2002;2:594-604
p53 in DNA Repair and Apoptosis
Tumor Suppressor p53
• Mutated/inactivated in a majority of human cancers
• p53 -/- knockout mice embryos develop normally to term but after a few weeks the young mice develop numerous malignant tumors
• adenovirus introduced wild-type p53 markedly enhanced the anti-tumor effect of a common chemotherapeutic agent, cisplatin, in human non-small cell lung cancer cells, and in human colon cancer cells.
• Effectiveness of cancer therapy correlates with the ability to induce p53-dependent apoptotic response
Thank You